Press releaseBusiness Wire
Accendra Health
ACH · NYSE
$0.2554+$0.0352 (+15.99%)TodayMarket closed ·
Prev close $0.2202
Latest news
- Press releaseBusiness Wire
Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth
- Press releaseBusiness Wire
Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Press releaseBusiness Wire
Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value
- Press releaseBusiness Wire
Accendra Health Reports Second Quarter 2026 Financial Results
- Press releaseBusiness Wire
Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search
- Press releaseBusiness Wire
Accendra Health Announces Leadership Appointments in IT and Procurement
- Press releaseBusiness Wire
Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call
- Press releaseBusiness Wire
Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations
- Press releaseBusiness Wire
Accendra Health Announces Early Results of Offers and Consent Solicitations
- Press releaseBusiness Wire
Accendra Health Announces Offers and Consent Solicitations
- News
Earnings Scheduled For May 11, 2026
- Press releaseBusiness Wire
Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction
- Press releaseBusiness Wire
Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call
- News
Accendra Health, Inc. Common Stock Q4 Adj. EPS $0.21 Misses $0.22 Estimate, Sales $708.967M Miss $714.733M Estimate
- Press releaseBusiness Wire
Accendra Health Reports Fourth Quarter 2025 Financial Results
- News
Earnings Scheduled For February 19, 2026
- Press releaseBusiness Wire
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call
- Press releaseBusiness Wire
Accendra Health, Inc. to Begin Trading on NYSE under New Ticker "ACH"
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.